BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1004 related articles for article (PubMed ID: 19305374)

  • 1. Chronic hepatitis C in the advanced adult and elderly subjects.
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Petraccaro M
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):145-57. PubMed ID: 19305374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
    Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
    J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection.
    Zou Z; Li B; Xu D; Zhang Z; Zhao JM; Zhou G; Sun Y; Huang L; Fu J; Yang Y; Jin L; Zhang W; Zhao J; Sun Y; Xin S; Wang FS
    J Clin Gastroenterol; 2009 Feb; 43(2):182-90. PubMed ID: 18633332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.
    Oliviero B; Varchetta S; Paudice E; Michelone G; Zaramella M; Mavilio D; De Filippi F; Bruno S; Mondelli MU
    Gastroenterology; 2009 Sep; 137(3):1151-60, 1160.e1-7. PubMed ID: 19470388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood T, B, and NK cells in relation to histological hepatitis activity and fibrosis stage in chronic hepatitis C.
    Panasiuk A; Prokopowicz D; Zak J; Wysocka J
    Hepatogastroenterology; 2003; 50(49):178-82. PubMed ID: 12630018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
    Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
    Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection.
    Abel M; Sène D; Pol S; Bourlière M; Poynard T; Charlotte F; Cacoub P; Caillat-Zucman S
    Hepatology; 2006 Dec; 44(6):1607-16. PubMed ID: 17133491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.
    Fisicaro P; Valdatta C; Boni C; Massari M; Mori C; Zerbini A; Orlandini A; Sacchelli L; Missale G; Ferrari C
    Gut; 2009 Jul; 58(7):974-82. PubMed ID: 19201769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems.
    Warrington KJ; Takemura S; Goronzy JJ; Weyand CM
    Arthritis Rheum; 2001 Jan; 44(1):13-20. PubMed ID: 11212151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence.
    Golden-Mason L; Burton JR; Castelblanco N; Klarquist J; Benlloch S; Wang C; Rosen HR
    Hepatology; 2006 Nov; 44(5):1098-109. PubMed ID: 17058243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of liver T-cell receptor gammadelta T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infections.
    Tseng CT; Miskovsky E; Houghton M; Klimpel GR
    Hepatology; 2001 May; 33(5):1312-20. PubMed ID: 11343261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines.
    D'Agosto G; Trento E; Nosotti L; Bordignon V; Battista M; Prignano G; Pimpinelli F; Biolcati G; Macrì A; Palamara G; Miglioresi L; Morrone A; Di Carlo A; Cordiali-Fei P; Ensoli F
    J Biol Regul Homeost Agents; 2009; 23(3):155-64. PubMed ID: 19828092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immune system in extreme longevity.
    Sansoni P; Vescovini R; Fagnoni F; Biasini C; Zanni F; Zanlari L; Telera A; Lucchini G; Passeri G; Monti D; Franceschi C; Passeri M
    Exp Gerontol; 2008 Feb; 43(2):61-5. PubMed ID: 17870272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
    Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
    Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease.
    Azeredo EL; De Oliveira-Pinto LM; Zagne SM; Cerqueira DI; Nogueira RM; Kubelka CF
    Clin Exp Immunol; 2006 Feb; 143(2):345-56. PubMed ID: 16412060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porcine T lymphocytes and NK cells--an update.
    Gerner W; Käser T; Saalmüller A
    Dev Comp Immunol; 2009 Mar; 33(3):310-20. PubMed ID: 18601948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C.
    Leroy V; Vigan I; Mosnier JF; Dufeu-Duchesne T; Pernollet M; Zarski JP; Marche PN; Jouvin-Marche E
    Hepatology; 2003 Oct; 38(4):829-41. PubMed ID: 14512870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased proportion of the CD56(bright) NK cell subset in patients chronically infected with hepatitis C virus (HCV) receiving interferon-alpha and ribavirin therapy.
    Lee S; Watson MW; Flexman JP; Cheng W; Hammond T; Price P
    J Med Virol; 2010 Apr; 82(4):568-74. PubMed ID: 20166183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of dysfunctional effector CD8+ T cells in the liver of patients with chronic HCV infection.
    Nisii C; Tempestilli M; Agrati C; Poccia F; Tocci G; Longo MA; D'Offizi G; Tersigni R; Lo Iacono O; Antonucci G; Oliva A
    J Hepatol; 2006 Mar; 44(3):475-83. PubMed ID: 16426698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.